GlassScriptPhysician profile
Tracie L Krob
NPI 1104968171
$3,118.34
in general payments reported to CMS, 2019-2025
24 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.92 · 2022: $970 · 2023: $1,476 · 2024: $521 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065 · Education: $48.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.16 |
| Education | $48.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,323.20 | 2022-2024 | Fasenra, Breztri, Airsupra |
| Grifols USA, LLC | $287.34 | 2021-2023 | Prolastin-C Liquid, Xembify |
| Mylan Specialty L.P. | $259.62 | 2023-2024 | Yupelri, Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.42 | 2022-2024 | Spiriva Respimat, Ofev |
| Glaxosmithkline, LLC. | $197.46 | 2022-2024 | Nucala |
| Genzyme Corporation | $111.15 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $91.88 | 2022-2024 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $87.14 | 2022-2023 | Uptravi, Opsumit |
| Genentech USA, INC. | $83.05 | 2022-2023 | Xolair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.22 | 2025 | Lifevest |
| Resmed Corp | $48.07 | 2023 | |
| Abbvie INC. | $40.38 | 2022 | |
| Pfizer INC. | $37.57 | 2023-2024 | |
| Amgen INC. | $37.15 | 2025 | Repatha |
| Mallinckrodt Hospital Products INC. | $35.45 | 2022-2023 | Acthar |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $28.13 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Medtronic, INC. | $21.84 | 2025 | Azure Xt Dr Mri Surescan |
| Harmony Biosciences LLC | $21.04 | 2023 | Wakix |
| Teva Pharmaceuticals USA, INC. | $19.38 | 2022 | |
| Zoll Respicardia, INC. | $18.59 | 2023 | Remede System |
| Novartis Pharmaceuticals Corporation | $17.29 | 2024 | |
| Insmed, INC. | $16.78 | 2021 | |
| Merck Sharp & Dohme LLC | $15.81 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Krob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.